| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 497 | 2021 |
| Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies MP Sormani, M Inglese, I Schiavetti, L Carmisciano, A Laroni, C Lapucci, ... EBioMedicine 72, 2021 | 201 | 2021 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of Clinical and Translational Neurology 8 (8), 1738-1744, 2021 | 118 | 2021 |
| Estimated prevalence of multiple sclerosis in Italy in 2015 MA Battaglia, D Bezzini Neurological sciences 38 (3), 473-479, 2017 | 77 | 2017 |
| Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs M Ponzio, S Gerzeli, G Brichetto, D Bezzini, GL Mancardi, P Zaratin, ... Neurological Sciences 36, 227-234, 2015 | 68 | 2015 |
| Multiple sclerosis epidemiology in Europe D Bezzini, MA Battaglia Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer …, 2017 | 65 | 2017 |
| Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy MP Sormani, I Schiavetti, M Inglese, L Carmisciano, A Laroni, C Lapucci, ... EBioMedicine 80, 2022 | 64 | 2022 |
| Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes T Manacorda, P Bandiera, F Terzuoli, M Ponzio, G Brichetto, P Zaratin, ... Journal of health services research & policy 26 (3), 189-197, 2021 | 55 | 2021 |
| SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study MP Sormani, I Schiavetti, D Landi, L Carmisciano, N De Rossi, C Cordioli, ... Multiple Sclerosis Journal 28 (7), 1034-1040, 2022 | 45 | 2022 |
| Prevalence of multiple sclerosis in Tuscany (Central Italy): a study based on validated administrative data D Bezzini, L Policardo, G Meucci, M Ulivelli, S Bartalini, F Profili, ... Neuroepidemiology 46 (1), 37-42, 2016 | 39 | 2016 |
| Methods of disinfecting stethoscopes: systematic review M Napolitani, D Bezzini, F Moirano, C Bedogni, G Messina International Journal of Environmental Research and Public Health 17 (6), 1856, 2020 | 32 | 2020 |
| First wave of COVID-19 pandemic in Italy: data and evidence D Bezzini, I Schiavetti, T Manacorda, G Franzone, MA Battaglia Coronavirus Therapeutics–Volume II: Clinical Management and Public Health …, 2022 | 31 | 2022 |
| Patients with multiple sclerosis: a burden and cost of illness study MA Battaglia, D Bezzini, I Cecchini, C Cordioli, F Fiorentino, T Manacorda, ... Journal of Neurology 269 (9), 5127-5135, 2022 | 24 | 2022 |
| Post-traumatic stress disorder in Italy: a comprehensive evaluation of all the ICD comorbidities and gender-related differences F Ferretti, A Pozza, L Bossini, S Desantis, M Olivola, L Del Matto, ... BMC research notes 12, 1-6, 2019 | 21 | 2019 |
| Automatic vending-machines contamination: a pilot study R Cardaci, S Burgassi, D Golinelli, N Nante, MA Battaglia, D Bezzini, ... Global Journal of Health Science 9 (2), 63, 2016 | 20 | 2016 |
| Increasing prevalence of multiple sclerosis in Tuscany, Italy D Bezzini, M Ulivelli, E Gualdani, M Razzanelli, F Ferretti, G Meucci, ... Neurological Sciences 41, 397-402, 2020 | 18 | 2020 |
| Multiple sclerosis incidence in Tuscany from administrative data D Bezzini, L Policardo, F Profili, G Meucci, M Ulivelli, S Bartalini, ... Neurological Sciences 39, 1881-1885, 2018 | 16 | 2018 |
| Signs and symptoms of COVID‐19 in patients with multiple sclerosis I Schiavetti, L Carmisciano, M Ponzano, C Cordioli, E Cocco, GA Marfia, ... European journal of neurology 29 (12), 3728-3736, 2022 | 11 | 2022 |
| Mortality of Parkinson’s disease in Italy from 1980 to 2015 M Ulivelli, D Bezzini, L Kundisova, I Grazi, MA Battaglia, N Nante, S Rossi Neurological Sciences 43 (6), 3603-3611, 2022 | 10 | 2022 |
| Antibody response elicited by the SARS‐CoV‐2 vaccine booster in patients with multiple sclerosis: Who gains from it? I Schiavetti, M Inglese, J Frau, E Signoriello, F Caleri, ML Stromillo, ... European Journal of Neurology 30 (8), 2357-2364, 2023 | 8 | 2023 |
Monica Ulivelliuniversità degli Studi di Siena在 unisi.it 的电子邮件经过验证
